Medipal Holdings Corporation (JP:7459)
:7459
Want to see JP:7459 full AI Analyst Report?
7459 Stock Chart & Stats
¥2847.00
-¥35.00(-1.46%)
At close: 4:00 PM EST
¥2847.00
-¥35.00(-1.46%)
Day’s Range― - ―
52-Week Range¥2,293.50 - ¥3,070.00
Previous CloseN/A
Volume297.80K
Average Volume (3M)365.88K
Market Cap
¥484.83B
Enterprise Value¥273.23B
Total Cash (Recent Filing)¥246.03B
Total Debt (Recent Filing)¥38.85B
Price to Earnings (P/E)12.8
Beta0.48
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.27%
Share Statistics
EPS (TTM)196.37
Shares Outstanding215,975,040
10 Day Avg. Volume365,940
30 Day Avg. Volume365,883
Financial Highlights & Ratios
PEG Ratio2.04
Price to Book (P/B)0.93
Price to Sales (P/S)0.16
P/FCF Ratio15.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,700.00Price Target Upside-5.16% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)198.3
Revenue Forecast (FY)¥3.92T
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage preserves financial flexibility, reduces bankruptcy risk, and enables investment in logistics, inventory and M&A. Rising equity from ~523B (2021) to ~652B (2026) strengthens the capital base, supporting long-term distribution scale and resilience against cyclical pressures.
Steady Revenue GrowthConsistent top-line growth across multiple years indicates resilient demand for core distribution services, supporting purchasing scale and logistics utilization. A stable revenue runway helps absorb margin pressure and underpins recurring cash flows from healthcare customers over the medium term.
Positive Cash GenerationRecurrent positive free cash flow in several recent years demonstrates the group's ability to convert earnings into cash, funding dividends, working capital and modest capex without heavy borrowing. This supports steady investment in logistics and inventory systems that sustain the distribution moat.
Bears Say
Thin Net MarginsStructural net margins near 1% leave little buffer for input cost inflation, pricing pressure, or reimbursement changes. Low margins constrain the firm's ability to self-fund large strategic initiatives and make earnings volatile relative to small swings in procurement or selling prices over coming quarters.
Cash-Flow VariabilityWorking-capital swings have produced uneven operating cash flows, reducing predictability for investment and dividends. The recent decline in 2026 versus 2025 highlights collection or inventory management risks that can impair liquidity planning and raise financing needs in stressed periods.
Operating Profit VolatilityEBIT falling despite revenue growth suggests pressure on operating leverage or rising logistics/SG&A costs. This indicates limited ability to translate scale into sustainable margin expansion, increasing the risk that volume growth will not reliably drive higher operating profits in the near term.
Medipal Holdings News
7459 FAQ
What was Medipal Holdings Corporation’s price range in the past 12 months?
Medipal Holdings Corporation lowest stock price was ¥2293.50 and its highest was ¥3070.00 in the past 12 months.
What is Medipal Holdings Corporation’s market cap?
Medipal Holdings Corporation’s market cap is ¥484.83B.
When is Medipal Holdings Corporation’s upcoming earnings report date?
Medipal Holdings Corporation’s upcoming earnings report date is Jul 24, 2026 which is in 45 days.
How were Medipal Holdings Corporation’s earnings last quarter?
Medipal Holdings Corporation released its earnings results on May 14, 2026. The company reported ¥25.19 earnings per share for the quarter, missing the consensus estimate of ¥38.24 by -¥13.05.
Is Medipal Holdings Corporation overvalued?
According to Wall Street analysts Medipal Holdings Corporation’s price is currently Overvalued.
Does Medipal Holdings Corporation pay dividends?
Medipal Holdings Corporation pays a Semiannually dividend of ¥34 which represents an annual dividend yield of 2.27%. See more information on Medipal Holdings Corporation dividends here
What is Medipal Holdings Corporation’s EPS estimate?
Medipal Holdings Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medipal Holdings Corporation have?
Medipal Holdings Corporation has 215,975,040 shares outstanding.
What happened to Medipal Holdings Corporation’s price movement after its last earnings report?
Medipal Holdings Corporation reported an EPS of ¥25.19 in its last earnings report, missing expectations of ¥38.24. Following the earnings report the stock price went down -1.566%.
Which hedge fund is a major shareholder of Medipal Holdings Corporation?
Currently, no hedge funds are holding shares in JP:7459
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medipal Holdings Corporation
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
7459 Stock 12 Month Forecast
Average Price Target
¥2,700.00
▼(-5.16% Downside)
Technical Analysis
Alfresa Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---